Buy Neuralstem Stock | CUR Stock Price & Latest News | Public.com
CUR

Neuralstem

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Neuralstem (CUR) stock trends here

    About CUR

    Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small mol...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap$23,17M
    Volume530,39k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$2.20
    1 Year Low$0.50
    Open$1.40
    High$1.42
    Low$1.26

    Buy any stock with any amount of money.

    Download the App
    Download the app